IBDEI35X ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,50499,1,4,0)
 ;;=4^N32.89
 ;;^UTILITY(U,$J,358.3,50499,2)
 ;;=^87989
 ;;^UTILITY(U,$J,358.3,50500,0)
 ;;=N33.^^193^2494^6
 ;;^UTILITY(U,$J,358.3,50500,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50500,1,3,0)
 ;;=3^Bladder Disorders,Diseases Classified Elsewhere
 ;;^UTILITY(U,$J,358.3,50500,1,4,0)
 ;;=4^N33.
 ;;^UTILITY(U,$J,358.3,50500,2)
 ;;=^5015654
 ;;^UTILITY(U,$J,358.3,50501,0)
 ;;=N34.2^^193^2494^113
 ;;^UTILITY(U,$J,358.3,50501,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50501,1,3,0)
 ;;=3^Urethritis
 ;;^UTILITY(U,$J,358.3,50501,1,4,0)
 ;;=4^N34.2
 ;;^UTILITY(U,$J,358.3,50501,2)
 ;;=^88231
 ;;^UTILITY(U,$J,358.3,50502,0)
 ;;=N34.1^^193^2494^114
 ;;^UTILITY(U,$J,358.3,50502,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50502,1,3,0)
 ;;=3^Urethritis,Nonspec
 ;;^UTILITY(U,$J,358.3,50502,1,4,0)
 ;;=4^N34.1
 ;;^UTILITY(U,$J,358.3,50502,2)
 ;;=^5015655
 ;;^UTILITY(U,$J,358.3,50503,0)
 ;;=N39.0^^193^2494^118
 ;;^UTILITY(U,$J,358.3,50503,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50503,1,3,0)
 ;;=3^Urinary Tract Infection,Site Not Spec
 ;;^UTILITY(U,$J,358.3,50503,1,4,0)
 ;;=4^N39.0
 ;;^UTILITY(U,$J,358.3,50503,2)
 ;;=^124436
 ;;^UTILITY(U,$J,358.3,50504,0)
 ;;=N31.0^^193^2494^79
 ;;^UTILITY(U,$J,358.3,50504,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50504,1,3,0)
 ;;=3^Neuropathic Bladder,Uninhibited NEC
 ;;^UTILITY(U,$J,358.3,50504,1,4,0)
 ;;=4^N31.0
 ;;^UTILITY(U,$J,358.3,50504,2)
 ;;=^5015644
 ;;^UTILITY(U,$J,358.3,50505,0)
 ;;=R31.9^^193^2494^58
 ;;^UTILITY(U,$J,358.3,50505,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50505,1,3,0)
 ;;=3^Hematuria,Unspec
 ;;^UTILITY(U,$J,358.3,50505,1,4,0)
 ;;=4^R31.9
 ;;^UTILITY(U,$J,358.3,50505,2)
 ;;=^5019328
 ;;^UTILITY(U,$J,358.3,50506,0)
 ;;=R31.0^^193^2494^55
 ;;^UTILITY(U,$J,358.3,50506,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50506,1,3,0)
 ;;=3^Hematuria,Gross
 ;;^UTILITY(U,$J,358.3,50506,1,4,0)
 ;;=4^R31.0
 ;;^UTILITY(U,$J,358.3,50506,2)
 ;;=^5019325
 ;;^UTILITY(U,$J,358.3,50507,0)
 ;;=R31.1^^193^2494^54
 ;;^UTILITY(U,$J,358.3,50507,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50507,1,3,0)
 ;;=3^Hematuria,Benign Essential Microscopic
 ;;^UTILITY(U,$J,358.3,50507,1,4,0)
 ;;=4^R31.1
 ;;^UTILITY(U,$J,358.3,50507,2)
 ;;=^5019326
 ;;^UTILITY(U,$J,358.3,50508,0)
 ;;=N40.0^^193^2494^3
 ;;^UTILITY(U,$J,358.3,50508,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50508,1,3,0)
 ;;=3^BPH w/o Lower Urinary Tract Symptoms
 ;;^UTILITY(U,$J,358.3,50508,1,4,0)
 ;;=4^N40.0
 ;;^UTILITY(U,$J,358.3,50508,2)
 ;;=^5015689
 ;;^UTILITY(U,$J,358.3,50509,0)
 ;;=N40.1^^193^2494^2
 ;;^UTILITY(U,$J,358.3,50509,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50509,1,3,0)
 ;;=3^BPH w/ Lower Urinary Tract Symptoms
 ;;^UTILITY(U,$J,358.3,50509,1,4,0)
 ;;=4^N40.1
 ;;^UTILITY(U,$J,358.3,50509,2)
 ;;=^5015690
 ;;^UTILITY(U,$J,358.3,50510,0)
 ;;=N41.0^^193^2494^89
 ;;^UTILITY(U,$J,358.3,50510,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50510,1,3,0)
 ;;=3^Prostatitis,Acute
 ;;^UTILITY(U,$J,358.3,50510,1,4,0)
 ;;=4^N41.0
 ;;^UTILITY(U,$J,358.3,50510,2)
 ;;=^259106
 ;;^UTILITY(U,$J,358.3,50511,0)
 ;;=N45.1^^193^2494^31
 ;;^UTILITY(U,$J,358.3,50511,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50511,1,3,0)
 ;;=3^Epididymitis
 ;;^UTILITY(U,$J,358.3,50511,1,4,0)
 ;;=4^N45.1
 ;;^UTILITY(U,$J,358.3,50511,2)
 ;;=^41396
 ;;^UTILITY(U,$J,358.3,50512,0)
 ;;=N45.2^^193^2494^81
